5A02.0

ICD-11 MMS 2026-01

Thyrotoxicosis with diffuse goitre

Description

Thyrotoxicosis with diffuse goitre (also known as Graves disease or Basedow disease) is a form of autoimmune thyroid disease and is the leading cause of hyperthyroidism and thyrotoxicosis. In this condition, thyroid-stimulating immunoglobulins bind to and activate the TSH receptor, resulting in excessive thyroid hormone production. The disease is characterized by goiter, rapid and irregular heartbeat, weight loss, irritability, anxiety, and often a (slight) protrusion of the eyeballs.

Index terms

  • Thyrotoxicosis with diffuse goitre
  • Basedow disease
  • Flajani disease
Show allHide
  • Graves disease
  • Graves disease with exophthalmos
  • Parry disease
  • Stokes disease
  • exophthalmic goitre
  • exophthalmic struma
  • goitre with hyperthyroidism
  • hyperthyroid goitre
  • hyperthyroidism struma
  • malignant exophthalmos
  • thyroid exophthalmos
  • thyrotoxicosis struma
  • thyrotoxicosis with goitre
  • toxic diffuse goitre
  • toxic diffuse goitre with exophthalmos
  • toxic goitre
  • toxic goitre NOS
  • toxic primary thyroid hyperplasia
  • Thyroid eye disease
  • ophthalmic Graves disease
  • thyroid-associated ophthalmopathy

Inclusions

  • Graves disease
  • toxic diffuse goitre

Exclusions from above levels

  • KB62.0 – Transitory neonatal hyperthyroidism
  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Sibling codes

  • 5A02.1 – Thyrotoxicosis with toxic single thyroid nodule
  • 5A02.2 – Thyrotoxicosis with toxic multinodular goitre
  • 5A02.3 – Thyrotoxicosis from ectopic thyroid tissue
  • 5A02.4 – Thyrotoxicosis factitia
  • 5A02.5 – Thyroid crisis
  • 5A02.6 – Secondary hyperthyroidism
  • 5A02.Y – Other specified thyrotoxicosis
  • 5A02.Z – Thyrotoxicosis, unspecified

Foundation entity

Thyrotoxicosis with diffuse goitre – http://id.who.int/icd/entity/713028385

Allowed postcoordination axes

Part of: 5A02: Thyrotoxicosis › 05: Endocrine, nutritional or metabolic diseases